BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2107114)

  • 1. Oral prostaglandin E analogues induce intestinal migrating motor complexes after a meal in dogs. Evidence for a central mechanism.
    Staumont G; Fioramonti J; Frexinos J; Bueno L
    Gastroenterology; 1990 Apr; 98(4):888-93. PubMed ID: 2107114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of endogenous prostaglandins on postprandial pyloric motility: a possible modulation by fats.
    Lopez Y; Fioramonti J; Bueno L
    Prostaglandins; 1991 Oct; 42(4):313-20. PubMed ID: 1796147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of corticotropin-releasing factor on plasma motilin and somatostatin levels and gastrointestinal motility in dogs.
    Bueno L; Fargeas MJ; Gue M; Peeters TL; Bormans V; Fioramonti J
    Gastroenterology; 1986 Oct; 91(4):884-9. PubMed ID: 2875010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central control of intestinal motility by prostaglandins: a mediator of the actions of several peptides in rats and dogs.
    Bueno L; Fargeas MJ; Fioramonti J; Primi MP
    Gastroenterology; 1985 Jun; 88(6):1888-94. PubMed ID: 3858191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic prostaglandin E2 analogue, enprostil, hastens gastric emptying of solids in patients with an active duodenal ulcer.
    Nowak A; Jonderko K; Nowakowska-Duława E; Adamczak D; Rudzka J; Nowak S
    Scand J Gastroenterol; 1990 Nov; 25(11):1118-22. PubMed ID: 2125742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of central and peripheral administration of dopamine on pattern of intestinal motility in dogs.
    Fioramonti J; Fargeas MJ; Honde C; Bueno L
    Dig Dis Sci; 1984 Nov; 29(11):1023-7. PubMed ID: 6489081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral control of gastrointestinal and colonic motility by endogenous opiates in conscious dogs.
    Bueno L; Fioramonti J; Hondé C; Fargeas MJ; Primi MP
    Gastroenterology; 1985 Feb; 88(2):549-56. PubMed ID: 3965344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of four orally administered analogues of prostaglandin E1 and E2 on glucose tolerance and on the secretion of pancreatic and gastrointestinal hormones in man.
    Nauck M; Härter S; Ebert R; Creutzfeldt W
    Eur J Clin Invest; 1989 Jun; 19(3):298-305. PubMed ID: 2509214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of enprostil on duodeno-jejunal motility in man.
    Ducrotte P; Parent B; Masliah C; Joubert M; Colin R; Denis P
    Aliment Pharmacol Ther; 1990 Feb; 4(1):73-81. PubMed ID: 2129489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GR63799X--a novel prostanoid with selectivity for EP3 receptors.
    Bunce KT; Clayton NM; Coleman RA; Collington EW; Finch H; Humphray JM; Humphrey PP; Reeves JJ; Sheldrick RL; Stables R
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():379-82. PubMed ID: 1825574
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurotensin: a central neuromodulator of gastrointestinal motility in the dog.
    Bueno L; Fioramonti J; Fargeas MJ; Primi MP
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G15-9. PubMed ID: 3966557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Reynolds J; Duffy J; Saito T; Hunt JS; Sevelius H
    Horm Metab Res; 1988 Oct; 20(10):637-40. PubMed ID: 3146539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of gastrointestinal motility by loperamide in dogs.
    Fioramonti J; Fargeas MJ; Bueno L
    Dig Dis Sci; 1987 Jun; 32(6):641-6. PubMed ID: 3568951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral antagonistic action of trimebutine and kappa opioid substances on acoustic stress-induced gastric motor inhibition in dogs.
    Gué M; Pascaud X; Hondé C; Junien JL; Buéno L
    Eur J Pharmacol; 1988 Jan; 146(1):57-63. PubMed ID: 2895010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the jejunal migrating motor complex by gastric distension and feeding in the dog.
    Bull JS; Grundy D; Scratcherd T
    J Physiol; 1987 Dec; 394():381-92. PubMed ID: 3443971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy and prevention of peptic lesions by prostaglandins].
    Müller P; Dammann HG; Simon B
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of growth hormone-releasing factor (GRF) on intestinal motility in dogs: involvement of dopaminergic receptors.
    Bueno L; Fioramonti J; Primi MP
    Peptides; 1985; 6(3):403-7. PubMed ID: 2999724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of prostaglandins in control of intestinal motility.
    Thor P; Konturek JW; Konturek SJ; Anderson JH
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G353-9. PubMed ID: 3883808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antroduodenal motility studied by real-time ultrasonography. Effect of enprostil.
    Hausken T; Odegaard S; Berstad A
    Gastroenterology; 1991 Jan; 100(1):59-63. PubMed ID: 1898497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.